Alfredo Elias Gilio

Alfredo Elias Gilio

Auto-generated profile, based on publicly available information

Alfredo Elias Gilio

Hospital Universitário (HU) da Universidade de São Paulo (USP), São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Jornal de Pediatria
Verified
Journal Article
Open access
FMFlávio da Silva Mesquita
Flávio da Silva Mesquita
DODanielle Oliveira
Danielle Oliveira
DCDaniela Crema
Daniela Crema
CPCélia Miranda Nunes Pinez
Célia Miranda Nunes Pinez
TCThaís Cristina Colmanetti
Thaís Cristina Colmanetti
EDEdison Durigon
Edison Durigon
The aim of this study was to evaluate the QuickVue® RSV Test Kit (QUIDEL Corp, CA, USA) as a screening tool for respiratory syncytial virus in children with acute respiratory disease in comparison with the indirect immunofluorescence assay as gold standard. In Brazil, rapid antigen detection tests for respiratory syncytial virus are not routinely utilized as a diagnostic tool, except for the diagnosis of dengue and influenza. The authors retrospectively analyzed 486 nasopharyngeal aspirate samples from children under age 5 with acute respiratory infection, between December 2013 and August 2014, the samples were analyzed by indirect immunofluorescence assay and QuickVue® RSV Test kit. Samples with discordant results were analyzed by real time PCR and nucleotide sequencing. From 313 positive samples by immunofluorescence assays, 282 (90%) were also positive by the rapid antigen detection test, two were positive only by rapid antigen detection test, 33 were positive only by immunofluorescence assays, and 171 were positive by both methods. The 35 samples with discordant results were analyzed by real time PCR; the two samples positive only by rapid antigen detection test and the five positive only by immunofluorescence assays were also positive by real time PCR. There was no relation between the negativity by QuickVue® RSV Test and viral load or specific strain. The QuickVue® RSV Test showed sensitivity of 90%, specificity of 98.8%, predictive positive value of 99.3%, and negative predictive value of 94.6%, with accuracy of 93.2% and agreement κ index of 0.85 in comparison to immunofluorescence assay. This study demonstrated that the QuickVue® RSV Test Kit can be effective in early detection of Respiratory syncytial virus in nasopharyngeal aspirate and is reliable for use as a diagnostic tool in pediatrics.

1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
ACAna Paula de Carvalho Panzeri Carlotti
Ana Paula de Carvalho Panzeri Carlotti
WCWerther Brunow de Carvalho
Werther Brunow de Carvalho
CJCíntia Johnston
Cíntia Johnston
AGAlfredo Elias Gilio
Alfredo Elias Gilio
HMHeloisa Helena de Sousa Marques
Heloisa Helena de Sousa Marques
ADArtur Figueiredo Delgado
Artur Figueiredo Delgado
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a pandemic in March 2020, affecting millions of people worldwide. However, COVID-19 in pediatric patients represents 1-5% of all cases, and the risk for developing severe disease and critical illness is much lower in children with COVID-19 than in adults. Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease [...] Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), became a pandemic in March 2020, affecting millions of people worldwide. However, COVID-19 in pediatric patients represents 1-5% of all cases, and the risk for developing severe disease and critical illness is much lower in children with COVID-19 than in adults. Multisystem inflammatory syndrome in children (MIS-C), a possible complication of COVID-19, has been described as a hyperinflammatory condition with multiorgan involvement similar to that in Kawasaki disease

6 February 2023 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
RKRenato Kfouri
Renato Kfouri
MBMaria-Cristina De Cunto Brandileone
Maria-Cristina De Cunto Brandileone
MSMarco Aurelio Palazzi Safadi
Marco Aurelio Palazzi Safadi
RRRosana Richtmann
Rosana Richtmann
AGAlfredo E Gilio
Alfredo E Gilio
SISão Paulo Study Group for IPD
São Paulo Study Group for IPD
Chronic conditions increase the risk of invasive pneumococcal diseases (IPD). Pneumococcal vaccination remarkably reduced IPD morbimortality in vulnerable populations. In Brazil, pneumococcal vaccines are included in the National Immunization Program (PNI): PCV10 for < 2 years-old, and PPV23 for high risk-patients aged ≥ 2 years and institutionalized ≥ 60 years. PCV13 is available in private clinics and recommended in the PNI for individuals with certain underlying conditions. A retrospective study was performed using clinical data from all inpatients from five hospitals with IPD from 2016 to 2018 and the corresponding data on serotype and antimicrobial-non-susceptibility of pneumococcus. Vaccine-serotype-coverage was estimated. Patients were classified according to presence of comorbidities: healthy, without comorbidities; at-risk, included immunocompetent persons with specific medical conditions; high-risk, with immunocompromising conditions and others RESULTS: 406 IPD cases were evaluated. Among 324 cases with information on medical conditions, children < 5 years were mostly healthy (55.9%), while presence of comorbidity prevailed in adults ≥ 18 years old (> 82.0%). Presence of ≥1 risk condition was reported in ≥ 34.8% of adults. High-risk conditions were more frequent than at-risk in all age groups. Among high-risk comorbidity (n = 211), cancer (28%), HIV/AIDS (25.7%) and hematological diseases (24.5%) were the most frequent. Among at-risk conditions (n = 89), asthma (16.5%) and diabetes (8.1%) were the most frequent. Among 404 isolates, 42.9% belonged to five serotypes: 19A (14.1%), 3 (8.7%), 6C (7.7%), 4 and 8 (6.2% each); 19A and 6C expressed antimicrobial-non-susceptibility. The vaccine-serotype-coverage was: PCV10, 19.1%, PCV13, 43.8%; PCV15, 47.8%; PCV20, 62.9%; PCV21, 65.8%, and PPV23, 67.3%. Information on hospital outcome was available for 283 patients, of which 28.6% died. Mortality was 54.2% for those with meningitis. Vaccine with expanded valence of serotypes is necessary to offer broad prevention to IPD. The present data contribute to pneumococcal vaccination public health policies for vulnerable patients, mainly those with comorbidity and the elderly.

19 October 2021 in Vaccine: X
Verified
Journal Article
Open access
MLMateus Deckers Leme
Mateus Deckers Leme
AGAlfredo Elias Gilio
Alfredo Elias Gilio
Health workers are a risk population for many infectious diseases, which leads to a number of vaccines being routinely recommended for health care staff. Medical students are also prone to such hazards. This study accesses undergraduate medicine students’ compliance to recommended health-staff vaccination, and their reasons for noncompliance. An online questionnaire was sent to all undergraduates in a major public medical school in Brazil, asking about vaccination status to Hepatitis B, Measle-mumps-rubella, Varicella, Pertussis and Influenza, and reasons in case of noncompliance 146 students answered the questionnaire, (response rate 14,6%). Overall vaccination status showed 74,7% of students with incomplete vaccination in some way, with an increase in vaccination status toward the end of the course. The highest noncompliance rates were Pertussis (49,3%), Varicella (47,3%) and Influenza (30,1%) vaccines. The vaccine with the lowest noncompliance rate was measles (9,6%). During the course, the greatest increases in adequate vaccination status were Hepatitis B, from 53,2% in first-years to 93,2% by the end sixth year (chi-sq 21, p < 0,0001), and Influenza, from 48,9% to 91,5% (chi-sq 22,5, p < 0,00009). Main reasons given not to vaccinate were vaccination hesitancy for influenza and varicella (respectively 61% and 46%), and lack of awareness of the need to vaccinate for pertussis (53%). Overall vaccine coverage in medical students in Brazil is still far from optimal. There is a markedly high level of vaccine hesitancy and unawareness of need to vaccinate for some diseases, particularly pertussis and influenza. Clinical trial registry (Brazilian regulation boards): 24159119.3.0000.0065.

1 July 2003 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
SFSandra Elisabete FMUSP
Sandra Elisabete FMUSP
AGAlfredo E. Gilio
Alfredo E. Gilio
CMCristina R. Miyao
Cristina R. Miyao
MPMárcia M. C. Pahl
Márcia M. C. Pahl
JLJoão P. B. Lotufo
João P. B. Lotufo
YOYassuhiko Okay
Yassuhiko Okay
Nosocomial Respiratory Syncytial Virus Infection in a Pediatric Ward - Volume 24 Issue 7 - Sandra E. Vieira, Alfredo E. Gilio, Cristina R. Miyao, Márcia M. C. Pahl, João P. B. Lotufo, Noely Hein, Selma L. Betta, Edison L. Durigon, Viviane Botosso, Bernardo Ejzenberg, Yassuhiko Okay

9 August 2019 in Urology & Nephrology Open Access Journal
Verified
Journal Article
Open access
DLDenise Swei Lo
Denise Swei Lo
EBEliane Roseli Barreira
Eliane Roseli Barreira
AGAlfredo Elias Gilio
Alfredo Elias Gilio